Company Analysis Treace Medical Concepts, Inc.
1. Summary
Advantages
- Price (2.42 $) is less than fair price (7.34 $)
- Current debt level 32.08% is below 100% and has decreased over 5 years from 74.1%.
Disadvantages
- Dividends (0%) are below the sector average (0.544%).
- The stock's return over the last year (-65.38%) is lower than the sector average (-2.93%).
- The company's current efficiency (ROE=-44.45%) is lower than the sector average (ROE=109.03%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Treace Medical Concepts, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -2.4% | -13.4% | -0.6% |
| 90 days | -64.4% | -1.6% | 2.9% |
| 1 year | -65.4% | -2.9% | 21% |
TMCI vs Sector: Treace Medical Concepts, Inc. has significantly underperformed the "Healthcare" sector by -62.44% over the past year.
TMCI vs Market: Treace Medical Concepts, Inc. has significantly underperformed the market by -86.37% over the past year.
Stable price: TMCI is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: TMCI with weekly volatility of -1.26% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (2.42 $) is lower than the fair price (7.34 $).
Price significantly below the fair price: The current price (2.42 $) is 203.3% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-7.69) is higher than that of the sector as a whole (-205.4).
P/E vs Market: The company's P/E (-7.69) is higher than that of the market as a whole (-65.33).
5.3. P/BV
P/BV vs Sector: The company's P/BV (4.09) is lower than that of the sector as a whole (245).
P/BV vs Market: The company's P/BV (4.09) is lower than that of the market as a whole (51.39).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (2.21) is lower than that of the sector as a whole (61.67).
P/S vs Market: The company's P/S indicator (2.21) is lower than that of the market as a whole (138.73).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-12.37) is lower than that of the sector as a whole (12.25).
EV/Ebitda vs Market: The company's EV/Ebitda (-12.37) is higher than that of the market as a whole (-95.22).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 33.09% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (33.09%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-609.67%).
6.4. ROE
ROE vs Sector: The company's ROE (-44.45%) is lower than that of the sector as a whole (109.03%).
ROE vs Market: The company's ROE (-44.45%) is lower than that of the market as a whole (-6.23%).
6.6. ROA
ROA vs Sector: The company's ROA (-23.77%) is lower than that of the sector as a whole (-2.42%).
ROA vs Market: The company's ROA (-23.77%) is lower than that of the market as a whole (38.59%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-30.47%) is lower than that of the sector as a whole (0.8343%).
ROIC vs Market: The company's ROIC (-30.47%) is lower than that of the market as a whole (9.66%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.544%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
